← All signal stories
§ SignalMay 25, 2026 · Issue 52 · Story 9

Three Years of Continuous BCI Speech Sets a New Durability Bar for Neuroprosthetics

Casey Harrell's 3-year ALS speech implant record shifts the competitive question from 'does it work?' to 'can it last?'

9. Three Years of Continuous BCI Speech Sets a New Durability Bar for Neuroprosthetics

Casey Harrell, a man living with ALS-related paralysis, has now used a speech brain-computer interface continuously for nearly three years, making him what the research team calls "the first power user" of the technology. First implanted with a cortical electrode array in 2023, Harrell has accumulated thousands of hours of active use, communicating full sentences through neural signal decoding. The case, reported by MIT Technology Review on June 15, 2026, represents the longest documented real-world durability demonstration for a speech neuroprosthetic to date.

That durability record matters more than it might appear. Neuralink, Synchron, and BrainGate have all demonstrated short-window BCI functionality, but the competitive question in the field has quietly shifted from proof-of-concept to longevity. Electrode arrays degrade. Signal quality drifts. Most published BCI results reflect weeks or months of use, not years. Harrell's three-year record directly challenges the assumption that cortical implants face an inevitable performance cliff, and it gives academic BCI programs a concrete benchmark that commercial players like Neuralink now need to match or exceed in their own longitudinal data. Any company claiming clinical readiness without comparable durability numbers will face harder questions from regulators and potential trial participants alike.

The broader pattern here is that BCI is moving from demonstration to endurance sport. The FDA's Breakthrough Device pathway has already accelerated implant trials, and the next regulatory pressure point will be long-term safety and signal stability data. Watch for Synchron, whose endovascular Stentrode design avoids open-brain surgery, to respond with its own multi-year usage data. Whoever publishes credible three-plus-year outcomes first shapes what the FDA treats as the durability standard for the category.

Source: This man with ALS is "the first power user" of a brain implant that lets him speak